Skip to main content
. 2018 Apr 19;8:6247. doi: 10.1038/s41598-018-24717-0

Figure 1.

Figure 1

Generation of iPSCs from human fibroblasts heterozygous and homozygous for the H1069Q mutation of ATP7B. (A) Human fibroblasts from control (WT/H1069Q) and patient (H1069Q/H1069Q) were induced to reprogram and after 21 days the presence of pluripotent stem cell colonies was assessed by immunofluorescence for expression of the stemness markers Oct4 and Nanog. Nuclei are stained with DAPI. Scale bars: 100 µm. (B) Karyotype analysis of two clones of control and patient iPSCs showing no detectable aberration in chromosomes number and structure. (C) Two selected clones of control and patient iPSC were expanded and adapted to grow without feeder layer for at least 5 passages. The maintenance of the undifferentiated phenotype was assessed by immunofluorescence for stemness marker expression as in panel A. Scale bars: 50 µm.